C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
12/2011
12/01/2011	WO2011149419A1 Vaccine against streptococcal infections based on recombinant proteins
12/01/2011	WO2011147320A1 B cell activating factor antagonist and preparation method and use thereof
12/01/2011	WO2011147319A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases
12/01/2011	WO2011147138A1 Targeting fusion protein of interleukin and preparation method and use thereof
12/01/2011	WO2011147057A1 Anti-angiogenic fusion polypeptide, gene and use thereof
12/01/2011	WO2011123813A3 Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
12/01/2011	WO2011086143A3 Liver targeting domain antibodies
12/01/2011	WO2011063921A8 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors
12/01/2011	US20110294983 Single-chain antiparallel coiled coil proteins
12/01/2011	US20110294865 Methods of detecting a fragment of neurosecretory protein vgf for diagnosing alzheimer's disease
12/01/2011	US20110294748 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	US20110294697 System for detectng protease
12/01/2011	US20110294226 Survival motor Neurons (SMN) gene: a gene for spinal muscular atrophy
12/01/2011	US20110294135 Compositions and methods for analyte detection and quantitation
12/01/2011	US20110293704 Priming of an immune response
12/01/2011	US20110293621 Immunogenic polypeptides comprising a scaffold polypeptide and a l2 polypeptide or a fragment thereof
12/01/2011	US20110293620 Monoclonal Antibodies For Use In Diagnosis and Therapy of Cancers and Autoimmune Disease
12/01/2011	US20110293609 Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
12/01/2011	US20110293593 Siva 2 stabilization
12/01/2011	US20110293579 Bi-specific fusion proteins
12/01/2011	US20110293554 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases
12/01/2011	CA2800744A1 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	CA2800688A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases
12/01/2011	CA2800488A1 Single -chain variable fragment anti-cd133 antibodies and uses thereof
12/01/2011	CA2799136A1 Vaccine against streptococcal infections based on recombinant proteins
11/2011
11/30/2011	CN102262158A 重组融合蛋白质在快速诊断检测中的直接应用 Direct application of recombinant fusion protein of rapid diagnostic tests
11/30/2011	CN102260702A 一种内皮细胞生长因子融合蛋白及其在再生医学中的应用 An endothelial cell growth factor fusion protein and its application in regenerative medicine
11/30/2011	CN102260698A 大肠杆菌中表达PTA-linker-thanatin融合蛋白及其抗癌研究 PTA-linker-thanatin fusion proteins expressed in E. coli and cancer research
11/30/2011	CN102260697A 融合表达重组制备人β干扰素 Fusion Expression of recombinant human β-interferon preparation
11/30/2011	CN102260353A 靶向性白细胞介素融合蛋白及其制备方法与应用 Protein and its preparation method and application integration targeting interleukin
11/30/2011	CN102260352A 靶向性白细胞介素融合蛋白及其制备方法与应用 Protein and its preparation method and application integration targeting interleukin
11/30/2011	CN102260351A 流感病毒M2e蛋白的制备及其在抗甲型流感病毒中的应用 Preparation of influenza virus M2e protein and its application in anti-influenza viruses
11/30/2011	CN102260322A 幽门螺杆菌抗原肽及其应用 Helicobacter pylori antigen peptide and its application
11/30/2011	CN102258773A 酪氯酸蛋白激酶受体EphA2优势表位复合物及其制备方法和应用 Acid casein kinase receptor EphA2 epitope compound and preparation method and application
11/29/2011	US8067539 g-protein coupled receptor used in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception
11/29/2011	US8067229 Ucp4
11/29/2011	US8067016 Fusion proteins of Mycobacterium tuberculosis
11/29/2011	US8067010 Immunological herpes simplex virus antigens and methods for use thereof
11/29/2011	US8066994 Proteins comprising an IgG2 domain
11/29/2011	CA2484166C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/29/2011	CA2344764C Intein mediated peptide ligation
11/24/2011	WO2011145615A1 Nucleic acid for production of pluripotent stem cell
11/24/2011	WO2011145125A1 Chimeric biomarker for the early diagnosis and immunotherapy of cancer
11/24/2011	WO2011120135A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011120134A8 Antibodies with enhanced or suppressed effector function
11/24/2011	WO2011094430A3 Pro-angiogenic fragments of prominin-1 and uses thereof
11/24/2011	WO2011087934A3 Kexin-derived vaccines to prevent or treat fungal infections
11/24/2011	WO2011085070A3 Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts
11/24/2011	WO2011043814A3 Fluorescent proteins and uses thereof
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288011 Peptide therapeutic conjugates and uses thereof
11/24/2011	US20110288009 Leptin and leptin analog conjugates and uses thereof
11/24/2011	US20110288007 Biocidal fusion peptide comprising ll-37
11/24/2011	US20110288005 Alpha 1-antitrypsin compositions and methods of making and using same
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110287512 Compositions for linking zinc finger modules
11/24/2011	US20110287454 Methods for monoclonal antibody production
11/24/2011	US20110287410 Hepatitis-c virus testing
11/24/2011	US20110287041 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
11/24/2011	US20110287031 Covalently reactive transition state analogs and methods of use thereof
11/24/2011	US20110286976 Bi-specific fusion proteins
11/24/2011	US20110286934 Membrane transduction peptides, polynucleotides, and methods
11/24/2011	US20110286929 Multivalent constructs for therapeutic and diagnostic applications
11/24/2011	US20110286923 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	CA2798988A1 Novel dna-binding proteins and uses thereof
11/23/2011	EP2388271A2 Human Antibodies and Proteins
11/23/2011	EP2388270A2 Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388254A1 Bioluminescent protease assay
11/23/2011	EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011	EP1362105B1 Anti-interferon-alpha antibodies
11/23/2011	CN102251014A Cell apoptosis detection kit, and preparation method and application thereof
11/23/2011	CN102250255A Genetic engineering protein TAT-VP28-GH capable of resisting white spot syndrome virus (WSSV) as well as preparation and application thereof
11/23/2011	CN102250254A Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) fusion protein, its preparation and applications
11/23/2011	CN102250253A Fusogenic peptide containing thrombin fragment
11/23/2011	CN102250252A Gastrin-releasing peptide (GRP) guided fusion protein
11/23/2011	CN102250211A HLA-A*3303-Restricted WT1 Peptide and pharmaceutical composition comprising the same
11/23/2011	CN102247603A Method for promoting epidermal growth factor transdermal drug delivery of protein drug
11/22/2011	US8063182 Human TNF receptor fusion protein
11/22/2011	CA2372511C Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/22/2011	CA2276534C Recombinant fusion proteins based on ribosome-inactivating proteins of the mistletoe viscum album
11/22/2011	CA2258518C Recognition molecules interacting specifically with the active site or cleft of a target molecule
11/17/2011	WO2011143637A1 Improved complement receptor 2 (cr2) targeting groups
11/17/2011	WO2011142858A2 Chlorotoxin variants, conjugates, and methods for their use
11/17/2011	WO2011068538A3 General method for generating ultra-high affinity binding proteins
11/17/2011	WO2011044336A3 Human domain antibodies against components of the human insulin-like growth factor (igf) system
11/17/2011	US20110281800 Recombinant fusion proteins to growth hormone and serum albumin
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011	US20110280899 Novel Immunogenic Lipopeptides Comprising T-Helper And Cytotoxic T-Lymphocyte (CTL) Epitopes
11/17/2011	US20110280892 Toxin conjugated eph receptor antibodies
11/17/2011	US20110280889 High affinity t cell receptor and use thereof
11/17/2011	US20110280879 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
11/17/2011	US20110280873 MCP1-Ig FUSION VARIANTS
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	CA2799470A1 Humanized ttc and methods of use thereof
11/17/2011	CA2799192A1 Improved complement receptor 2 (cr2) targeting groups
11/17/2011	CA2799169A1 Chlorotoxin variants, conjugates, and methods for their use
11/16/2011	EP2386859A2 Diagnostic tumor markers

1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 295